Titre :
  • Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
Auteur : Pritchard, Kathleen ; Burris, Howard H.A. ; Ito, Yoshinori Y. ; Rugo, Hope ; Dakhil, Shaker S. ; Hortobagyi, Gabriel N. ; Campone, Mario ; Csöszi, Tibor T. ; Baselga, José ; Puttawibul, Puttisak P. ; Piccart-Gebhart, Martine ; Heng, Daniel Y C D.Y.C. ; Noguchi, Shinzaburo S. ; Srimuninnimit, Vichien V. ; Bourgeois, Hugues H. ; Gonzalez Martin, Antonio A. ; Osborne, Karen K. ; Panneerselvam, Ashok A. ; Taran, Tetiana T. ; Sahmoud, Tarek ; Gnant, Michael
Informations sur la publication : Clinical breast cancer, 13, 6, (page 421-432)
Statut de publication : Publié, 2013
Sujet CREF : Cancérologie
Mots-clés : Advanced breast cancer
Endocrine resistance
Geriatric
Progression-free survival
Safety
Mots-clés MeSH : Aged
Aged, 80 and over
Androstadienes -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
Female
Follow-Up Studies
Humans
International Agencies
Neoplasm Metastasis
Neoplasm Recurrence, Local -- drug therapy -- pathology
Neoplasm Staging
Prognosis
Receptor, ErbB-2 -- metabolism
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Safety
Sirolimus -- administration & dosage -- analogs & derivatives
Survival Rate
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:1526-8209 
info:doi/10.1016/j.clbc.2013.08.011
info:pii/S1526820913001857
info:pmid/24267730